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A bstrac t We used polymerase chain reaction (PCR)/sin- 
g I e-strand conformation polymorphism analysis and di­
rect sequencing of the coding region of the (3-glucuroni­
dase cDNA and gene to detect mutations causing (3-glu- 
curonidase enzyme deficiency in five MPS VII patients. 
Four patients presented with hydrops fetalis, one with an 
early infantile form of the disease. Genetic heterogeneity 
of MPS VII alleles was further confirmed in this study, 
Recurrent mutations were observed in patients of related 
origin. Previously unknown alleles detected were R110X,
F361A9, 1270 + 1G-»A, S52F and 1480A4. Reverse tran- 
scription/PCR analysis of the 1270 + 1G—>A messenger 
showed aberrant splicing: inclusion of intron 7 or skip­
ping of exons 6-7 and 9. Messenger RNA transcribed 
from the R110X and 1480A4 alleles was unstable. We de­
tected a 2154A/G change in the 3' non-coding region of 
the gene, in the neighbourhood of the two consensus poly­
adenylation sites. 3'-Rapid amplification of cDNA ends/ 
PCR of fibroblast cDNA revealed equal usage of two al­
ternative polyadenylation sites. The 2154A/G substitution 
did not influence adenylation-site choice, nor the amount 
of stable messenger produced. The finding that 2 out of 30
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normal controls carried the 2154G allele indicated that the 
2154A/G substitution is a harmless polymorphism. The 
S52F and F361A9 cDNAs were constructed in vitro and 
used to transfect COS cells transiently. Both mutations
completely abolished enzyme activity.
Introduction
Deficiency of the lysosomal enzyme (3-glucuronidase 
(E.C.3.2.1.31) causes mucopolysaccharidosis type VII 
(MPS VII; Sly et al. 1973; reviewed by Neufeld and 
Muenzer 1995). An extremely wide spectrum of clinical 
presentations of the disease has been observed. Diagnosis 
of the disease therefore greatly depends on laboratory 
findings, such as low (3-glucuronidase enzyme activity, 
mucopolysacchariduria and the presence of granulations 
in many tissues. The existence of a pseudodeficiency al­
lele for the (3-glucuronidase gene further complicates bio­
chemical diagnosis of MPS VII (Chabas et al. 1991; Ver­
voort et ai. 1995).
The cDNA and the gene coding for human (3-glucuro­
nidase have been cloned and characterized (Oshima et al. 
1987; Miller et al. 1990). Multiple unprocessed pseudo­
genes complicate the molecular analysis of the gene. 
Methods for selective amplification of the gene by the poly­
merase chain reaction (PCR) have been designed (Shipley 
et al. 1993; Vervoort et al. 1993, 1996), allowing genetic 
studies of MPS VII patients; these studies have shown ex­
tensive genetic heterogeneity (Tomatsu et al. 1990, 1991; 
Shipley et al. 1993; Vervoort et al. 1993, 1995, 1996; Wu 
and Sly 1993; Wu et al. 1994; Yamada et al. 1995). Ge­
netic heterogeneity has also been observed in a relatively 
homogeneous clinical phenotype (i.e. hydrops fetalis). In 
the present study, we have analysed the (3-glucuronidase 
gene and cDNA of five MPS VII patients. To investigate 
the effect of a 2154A/G change on polyadenylation and 
mRNA stability, we have used 3'-rapid amplification of 
cDNA ends (RACE)/PCR analysis of the (3-glucuronidase 
cDNA.
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Subjects, materials and methods
Subjects
Patient 1 was born to a non-consanguineous couple from the 
Netherlands. The index case was a 16-week hydropic fetus. Cul­
tured amniocytcs were available for study. Two previous pregnan­
cies resulted in an affected hydropic fetus. In the first pregnancy, 
which ended alter 34 weeks, hydrops was detected at week 25: in­
creased intra- and extra-medullary haematopoiesis were docu­
mented. In the second pregnancy, hydrops, granulocytopenia and 
anaemia were noted at week 15. One healthy child was born to this 
couple.
Patient 2 was of Mexican descent. The parents denied consan­
guinity. At 17 weeks, mild oedema was observed on ultrasound; 
the fetus developed ascites, pleural effusions and an echogenic 
bowel. Analysis of fetal umbilical blood lymphocytes by electron 
microscopy showed numerous lysosomes with a particulate con­
tent. The pregnancy was terminated at 23 weeks. Total RNA and 
genomic DNA were prepared from frozen tissue (heart, liver), One 
previous pregnancy ended with a 30-week fetal demise. The oede- 
matous baby was otherwise anatomically normal.
Patient 3 was a severely affected child from Czechoslovakia. 
Symptoms were present at birth: hepatosplenomegaly, pectus cari- 
natum and infundibular formation o f  the thorax. At 5 months of 
age, bilateral inguineal hernia, slight hypertelorism, hydroeoele 
and hypergranulation of leucocytes were observed. The infant had 
psychomotoric retardation and macrocephaly. Cultured fibroblasts 
were available for this study.
Patient 4, from Belgium, was described as a hydropic fetus 
(Lissens et al. 1991). Detection of the paternal mutation of this fe­
tus has been reported previously (Vervoort et al. 1993),
Patient 5 was a hydropic fetus o f  Belgian origin. Hydrops fe­
talis was noted on ultrasound in two previous pregnancies. In the 
first pregnancy, rapidly increasing ascites, subcutaneous oedema 
and placental thickening were noted at 22 weeks. Echocardiogra­
phy showed no structural cardiac defects or arrhythmia. Mi­
croscopy of the placenta showed prominently vacuolated Hofbauer 
cells. Histology o f  the fetus showed numerous vacuolated macro­
phages in liver, spleen, lymph nodes and bone marrow. Scattered 
foamy macrophages were seen in the lungs, the myocardium, the 
adrenals and the kidneys. Renal tubular cells were vacuolated but 
stained only faintly for mucopolysaccharides. Microscopically, the 
heart showed a slightly thickened fibrotic endocardium. In the sec­
ond pregnancy, oedem a of the neck and the back was noted at 12 
w eeks’ gestation (this neck oedema had also been seen at an early 
stage in the first pregnancy). As in the previous fetus, no other 
macroscopic abnormalities were found. The third fetus was also 
hydropic and, at autopsy, no other abnormalities were found. Cul­
tured amniocytes o f  the third pregnancy were used for mutation 
analysis.
RNA preparation, reverse transcription/PCR,
single-strand conformation polymorphism analysis and sequencing
Isolation of total RNA, reverse transcription (RT)/PCR, single- 
strand conformation polymorphism analysis (SSCP) and sequenc­
ing o f  PCR products were performed as reported previously (Ver­
voort et al. 1996). The oligonucleotides used here for PCR and se­
quencing were as defined in Shipley et al. (1993) and Vervoort et 
al. (1996).
Genomic DNA preparation, PCR, SSCP and sequencing
Genomic DNA was prepared from the material available. Amplifi­
cation with PCR, SSCP and sequencing o f  PCR products were per­
formed as reported previously (Vervoort et al. 1996). To amplify 
the promoter region and exon 1 of the |3-glucuronidase gene, we used 
primer pair R A F 2 6 - / r  as described; a second PCR amplification of
this product with hemi-nesting primer pairs RAF26-RAF25 and 
R A F ! - / r  was employed. These PCR products were better tem ­
plates for direct sequencing. Exon 9 sequences were determined in 
the sense direction by RAF 13. with a cycle sequencing protocol 
(Thermo-Sequenase. A me rs ham).
3 -Rapid amplification of cDNA ends/PCR
For 3'-rapid amplification of cDNA ends (RACE), we used a kit for 
RT-PCR from Perkin Elmer. However. RT was primed with the 
Not l-d(T)¡X primer supplied by Pharmacia. The first PCR amplifi­
cation was carried out with sense primer RAF13 and the Not27 an ­
tisense primer (consisting of the anchor portion of the Not 
primer). This product was reamplified with primer pair RAF 15- 
Not27 and the subsequent product was purified on agarose gel, 
reamplified and sequenced with primers RAF 15 and HUG 16; se ­
quencing o f  the 3 ' end was carried out with primer RAF48 (cDNA 
position 1981 "2000, 5'-G AGC A AG ACTG AT ACC A C C T -3'), by 
using Thermo-Sequenase (Amersham).
Expression studies
For expression in COS cells, mutations were introduced into the 
w'ild-type p-glucuronidase cDNA cloned in the expression vector 
pJC l 19 (Oshima et al. 1987). We amplified cDNA with PCR, d e ­
rived mutant restriction fragments and replaced the fragment in the 
expression vector. Mutant constructs were verified by sequencing 
the appropriate region o f  the cDNA.
Results
Detection of MPS VII mutations
Methods for mutation analysis of the [}-glucuronidase 
cDNA and gene have been described previously (Shipley 
et al, 1993; Vervoort et al. 1996). The deleterious alter­
ations found on MPS VII alleles of patients 1—5 are sum­
marized in Table 1 and Fig. 1. The 1107A27 deletion was 
easily detected when PCR products were run on agarose 
or polyacrylamide gels and were localized in a 55-nt in­
terval (nt 1092-1146). The second allele of patients I and 
5 resulted in greatly reduced amounts of stable mRNA 
(RNA-). Restriction analysis with Bglll of PCR-ampIified 
exons 6-7 from genomic DNA of patient 1 revealed an 
R357X allele. In order to find the MPS VII mutation on 
the second chromosome of patient 5, PCR fragments am­
plified from genomic DNA were sequenced; an 1480A4 
deletion of 4 nt in exon 9 was the only other change 
found. Aberrant PCR products amplified from the cDNA 
of patient 2 suggested a splice-site mutation. SSCP analy­
sis of PCR-amplified exons 6-7 and exons 7—8 from ge­
nomic DNA of this patient showed altered mobility of 
both fragments. Direct sequencing disclosed the 1270 -f- 
1G-^A transition in the first nucleotide of intron 7, local­
ized in the overlap of the fragments analysed with SSCP. 
As this change creates a new restriction site for Nlctlll, it 
could be confirmed unambiguously after digestion of 
PCR products with this enzyme. The R374C change (pa­
tient 3) was detected with PCR-SSCP and direct sequenc­
ing of the cDNA. Although the second allele of this pa­
tient was equally expressed in his mRNA, no other
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T ab ic  I Suminarv o f  MPS VII mutation analysis
Patient number 
and orinin
Phenotype Nucleotide
change*1
$
Amino
acid
change 1
Exon Effect on 
R N A 11
Haplotypec 
1766 1972 2154
Patient 1 Hydrops 1107A27 F361A9 7 — C c n.d.
The Netherlands 1095C-VT R357X 7 RNA- C c n.d.
Patient 2 Hydrops 1270 + 1G—>Ah — Intron 7 A berrán t c c n.d.
Mexican descent 1270+ 1G~-*A — Intron 7 splicing c c n.d,
Patient 3 Neonatal 1146C-VT R347C 7 — c T G d
Czechoslovakia 181 C—>T S52F 1 — c c A
Patient 4 Hydrops 672C—»T R216W 4 — c T A
Bel nium 354C-*T R110X 2 RNA- c T A
Patient 5 Hypdrops 1107A27 F361A9 7 — c c A
Belgium 14K0 A4 frameshift 9 RNA- c c A
Both alleles o f  each patient are given. -  No effect 
b Unable to exclude a full deletion of the p-glueuronidase gene on 
a patient’s second chromosome
L' Four polymorphic loci were analyzed: 1091 + 27C/G, 1766T/C, 
I972CYT and 2154A/G. The 1091 + 27C or G allele was always as­
sociated with the same 1972T or C allele, respectively; therefore, 
analysis o f  1091 + 27C/G is not listed, n.d. Not determined
d Three changes were found on both alleles o f  patient 3 (S52F, 
R374C, 2154G). The 2154A/G change is probably a (relative rare) 
harmless polymorphism. 2 I54G  was assigned to his R374C allele, 
since it was also found on the R374C allele o f  another MPS VII 
patient. As a consequence, the only change on the second allele o f  
patient 3 was the S52F missense mutation, which destroys enzyme 
activity completely in a transfection experiment
changes were disclosed with RT-PCR-SSCP. After com­
plete sequencing of the coding region of both the cDNA 
and the gene, we found that this patient also carried an 
S52F allele. Molecular analysis of the cDNA of the fourth 
patient showed that he was a compound heterozygote for 
a R216W allele and a second allele not stably expressed 
in his mRNA (Vervoort et al. 1993). After complete se- 
quencing of the coding region of the gene, a 354C—>T 
transition in exon 2, predicting a R110X premature termi­
nation, was found on his maternal allele.
Aberrant processing of the 1270 + 1G~~>A mRNA
cDNA of patient 2 was amplified with PCR and the prod­
ucts were analysed on polyacrylamide gel electrophoresis 
(PAGE). Aberrant bands were eluted, reamplified and se­
quenced (Fig. 2). A band amplified with RAF 11-RAF 12 
included a mutant (1270 + 1G—>A) intron 7; introns 8 and 
9 were spliced out correctly from this messenger, inclusion 
of an intron in the mRNA is not a common effect of 5'- 
splice mutations on mRNA (Scott et al. 1993). However, 
as a consequence of the multiplicity of aberrant splicing 
products and the length of most introns, these messengers 
are easily overlooked. Two short bands amplified with 
RAF9-RAF12 missed exons 6 and 7; the shortest product 
also missed exon 9 (Fig. 2). One aberrant product ampli­
fied with primers RAF9-RAF12 was also amplified from 
the cDNA of most other MPS VII patients; direct se­
quencing showed its sequence to be identical with that of 
nt 253-410 of SMA 4 cDNA (Theodosiou et al. 1994). 
SMA 4 is a member of a family of expressed sequences 
consisting of various combinations of p-glucuronidase-re- 
lated pseudoexons; PCR amplification of these sequences 
with our primers occurs accidentally when binding sites 
are conserved and are present in the correct orientation.
Additional polymorphisms in exon 12
Sequencing of the PCR product amplified from genomic 
DNA of patient 3 showed that he was heterozygous for a 
A—>G transition at position 2154, in the non-coding part 
of exon 12. Since patient 3 also carried an R374C and an 
S52F allele, the 2154G change could be on either allele. 
No material from relatives of this patient was available; 
therefore, we analysed position 2154 in another earner of 
R374C (German patient 8 in Vervoort et al. 1996). Sur­
prisingly, this patient was homozygous for 2154G. Thus, 
patient 3 and the German patient probably carry the same 
R374C-2154G allele and have a different MPS VII muta­
tion on their second chromosome. We screened 30 unre­
lated Belgian controls for 2154G with single-track se­
quencing of PCR-amplified exon 12. Two individuals car­
ried a 2154G allele (estimated allele frequency 3%). Sin­
gle-track sequencing of exon 12 disclosed an additional 
polymorphism located 3' of the wild-type polyadenylation 
site (and therefore not present in mRNA); one healthy in­
dividual was homozygous for 2243AGT (Fig. 1).
Alternative polyadenylation sites
To compare the expression of the 2154G and 2154A mes­
senger, we used 3'-RACE-PCR. 3'-RACE-PCR products 
were amplified from cDNA of patient 3 and of a control 
carrier of 2154G and directly sequenced. Sequencing re­
sults demonstrated that both alleles were almost equally 
represented in cDNA (Fig. 3).
When 3'-RACE products were directly sequenced, the 
involvement of two different polyadenylation sites was 
observed. The 3' end of the first cDNA was identical with 
the published 3' sequence; the second cDNA was 13 nt 
shorter (Fig. 3). Sequences derived from both messengers
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Fig. 4 Sequence environment o f  small deletions. The sequence 
surrounding the four small deletions is shown (nucleotides 1480A4, 
1107A27, 2243AGT and 1900AGA). The deleted sequence is boxed: 
direct repeats are underlined with hold arrows. Sequences found 
with increased frequency near small deletions (Cooper and Kraw- 
czak 1993) are underlined; sequences in the antisense strand are 
over lined
Nonsense mutations affecting mRNA quantity
Although the RT-PCR method used here provides no in­
formation on the absolute levels of mRNA expressed, it 
allows a comparison of mRNA levels synthesized from 
both alleles of a heterozygous patient. Analysis of the 
cDNA of patients I, 4 and 5 has revealed only one mutant 
allele. Analysis of genomic DNA is required to detect the 
mutation on the second allele, which has subsequently 
been confirmed to be absent in the cDNA (R357X, 
R110X, 1480A4); thus, these alleles produce greatly re­
duced levels of stable mRNA (RNA-). The present obser­
vations fit the translation-coupling model of Urlaub et al. 
(1989), a model that explains the 5/-to-3/ gradient of the 
influence of nonsense mutations on mRNA levels* Indeed, 
the R110X allele, mutated in exon 2, and the 1480A4 
frameshift, resulting in a premature stop codon in exon 
10, are RNA- alleles. It is interesting to note that 1107A27, 
which does not affect the reading frame, produces higher 
(and probably normal) levels of mRNA than that found in 
R357X and 1480A4.
Alternative polyadenylation in fibroblasts
Sequencing of S'-RACE-PCR products has disclosed the 
use of two alternative polyadenylation sites in fibroblasts. 
The longest messenger corresponds to the published cDNA 
(Oshima et al. 1987), the second is 10-13 nt shorter (Fig. 
3). Both 3' termini are amplified in equal amounts. Equal 
usage of both polyadenylation sites is not restricted to fi­
broblasts: it has also been observed when cDNA of Iym- 
phoblastoid cell lines is amplified (results not shown). 
Two consensus AATAAA signals are present near the 3' 
end of the (i-glucuronidase cDNA. Both cleavage sites are 
separated by 7-10  bp and 24 bp from the second signal. 
Since the usual distance between the signal and the poly­
adenylation site is 10-30 bp, only the second AATAAA 
signal may be functional.
The 2154A/G change is localized between the two 
polyadenylation signals. Nucleotide changes affecting 
polyadenylation are generally found in the consensus se­
quence; however, mutation of surrounding nucleotides 
might affect the efficiency of polyadenylation and, as a
consequence, affect mRNA levels in some cases (Cai et 
al. 1992). Studies of mammalian polyadenylation have 
demonstrated the importance of downstream or upstream 
efficiency elements (for a review on polyadenylation, see 
Manley 1995). Therefore, we have compared the expres­
sion of both 2154 alleles in two heterozygotes. Since 
equal amounts of both alleles are expressed, we conclude 
the 2154A/G change does not affect mRNA stability. Fur­
thermore, we have observed no influence of the 2154 hap- 
I o type on alternative polyadenylation in homo zygote s. 
These results, together with the relatively high allele fre­
quency (3%  in controls), demonstrate that the 2154A/G 
change is probably a harmless polymorphism.
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